menu
    • menu
    [{"orgOrder":0,"company":"Bio Products Laboratory","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Coagulation Factor X","moa":"Coagulation factor X||Factor Xa","graph1":"Hematology","graph2":"Approved FDF","graph3":"Bio Products Laboratory","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Bio Products Laboratory \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bio Products Laboratory \/ Undisclosed"},{"orgOrder":0,"company":"Kedrion","sponsor":"Worldwide Clinical Trials","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Coagulation Factor X","moa":"Coagulation factor X","graph1":"Hematology","graph2":"Phase III","graph3":"Kedrion","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kedrion \/ Worldwide Clinical Trials","highestDevelopmentStatusID":"10","companyTruncated":"Kedrion \/ Worldwide Clinical Trials"}]

    Find Clinical Drug Pipeline Developments & Deals for Coagulation Factor X

    Menu

    Coagulation Factor X

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Kedrion

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Kedrion

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Coagulation Factor X

                            Therapeutic Area : Hematology

                            Study Phase : Phase III

                            Sponsor : Worldwide Clinical Trials

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

                            Details : Coagadex (Coagulation Factor X) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Factor X Deficiency.

                            Product Name : Coagadex

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 08, 2025

                            Lead Product(s) : Coagulation Factor X

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase III

                            Sponsor : Worldwide Clinical Trials

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Bio Products Laboratory

                            United Kingdom arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Bio Products Laboratory

                            United Kingdom arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Coagulation Factor X (Human),Coagulation Factor X

                            Therapeutic Area : Hematology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            BPL Receives Orphan Drug Marketing Authorization for Coagadex® in Mexico

                            Details : Coagadex® is the first and only treatment specifically for Hereditary Factor X Deficiency, a very rare inherited clotting disorder that causes problems with blood clotting due to not having enough Factor X in the blood.

                            Product Name : Coagadex

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 04, 2022

                            Lead Product(s) : Coagulation Factor X (Human),Coagulation Factor X

                            Therapeutic Area : Hematology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth